Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $2,366,310.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK057966-02 | Phase II | 2,366,310 | ||||||||
A SBIR Phase I contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $250,001.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA016476-01 | Phase I | 250,001 | ||||||||
A SBIR Phase I contract was awarded to NOVASITE PHARMACEUTICALS, INC. from the U.S. Department of Health & Human Services. | SBIR | 2R44DK057966-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $148,940.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH068919-01 | Phase I | 148,940 | ||||||||
A SBIR Phase II contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $1,349,340.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH068919-02 | Phase II | 1,349,340 | ||||||||
A SBIR Phase II contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $1,558,890.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DA016476-02 | Phase II | 1,558,890 | ||||||||
A SBIR Phase I contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $250,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA097573-01A1 | Phase I | 250,000 | ||||||||
A SBIR Phase I contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $250,001.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA016474-01 | Phase I | 250,001 | ||||||||
A SBIR Phase I contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $183,589.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CM037011-000 | Phase I | 183,589 | ||||||||
A SBIR Phase I contract was awarded to NOVASITE PHARMACEUTICALS, INC. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 100,000 |